(lp0
S'BRIEF-Bio-Techne Corp &amp; Bio-Techne has entered into an exclusive license agreement Reuters - Mar 7, 2017 BRIEF-Bio-Techne Corp &amp; Bio-Techne has entered into an exclusive license agreement. March 7 Bio-techne Corp: * Bio-Techne Corp - Bio-Techne has entered into an exclusive license agreement with multiclonal therapeutics. * Bio-Techne Corp - agreement&nbsp;...'
p1
aS'Bio-Techne Corporation Completed its Acquisition of Advanced Cell Diagnostics PR Newswire  - Aug 1, 2016 MINNEAPOLIS, Aug. 1, 2016 /PRNewswire/ -- Bio-Techne Corporation  today announced it has completed its acquisition of Advanced Cell Diagnostics of Newark, CA.'
p2
aS'Bio-Techne Corp  Ex-Dividend Date Scheduled for February 15, 2017 Nasdaq - Feb 14, 2017 Bio-Techne Corp  will begin trading ex-dividend on February 15, 2017. A cash dividend payment of $0.32 per share is scheduled to be paid on March 03, 2017.Bio-Techne Corp  to Issue Quarterly Dividend of $0.32 on March 3rd - Sports Perspectives'
p3
aS'BIO-TECHNE Corp  Upgraded by Zacks Investment Research to Hold The Cerbat Gem - 10 hours ago BIO-TECHNE Corp logo Zacks Investment Research upgraded shares of BIO-TECHNE Corp  from a sell rating to a hold rating in a research note published on Tuesday.'
p4
aS'Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for ... PR Newswire  - Mar 7, 2017 Bio-Techne Corporation  is a leading developer and manufacturer of high quality purified proteinsnotably cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds --- which are sold&nbsp;...'
p5
aS'Bio-Techne Corp  Moves Higher on Volume Spike for March 17 Equities.com - Mar 17, 2017 Bio-Techne Corp  traded on unusually high volume on Mar. 17, as the stock gained 0.29% to close at $104.81. On the day, Bio-Techne Corp saw 346,203 shares trade hands on 2,517 trades. Considering that the stock averages only a daily volume of&nbsp;...The BIO-TECHNE Corp  Lifted to Hold at Zacks Investment Research - Petro Global News 24Bio-Techne Corp  Dividend Disbursement At $0.32 - Equities Focus'
p6
aS'Bio-Techne Corp. MarketWatch - Sep 2, 2009 Check out the returns on our 8 Lazy Portfolios that are made up of low-cost buy-and-hold index funds.  How to create your own Lazy Portfolio.'
p7
aS'The BIO-TECHNE Corp  Upgraded at Zacks Investment Research Petro Global News 24 - Mar 21, 2017 BIO-TECHNE Corp  was upgraded by Zacks Investment Research from a sell rating to a hold rating in a note issued to investors on Tuesday.Norges Bank Purchases Shares of 481788 BIO-TECHNE Corp  - The Cerbat Gem'
p8
aS'Innovative Veterinary Diagnostic Setting A New Standard PR Newswire  - Mar 1, 2017 MINNEAPOLIS, March 1, 2017 /PRNewswire/ -- Bio-Techne Corporation has partnered with Brazil-based DK Diagnostics to release its first diagnostic tool for the veterinary market.'
p9
aS'Staying Cautious On Bio-Techne For Now Seeking Alpha - Jul 17, 2016 The companys diversification strategy has provided a boost to sales, as margins have compressed. The strong performance of the shares makes shares relatively expensive for now, as I think that ambitious 2019 targets are not achievable.'
p10
a.